02179.HK
Jiangsu Recbio Technology Co., Ltd.
HKSE · Healthcare · Biotechnology · CN
HKD 4.91
−1.90%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 251.56x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.22x
- Price / sales
- 279.73x
- Price / cash flow
- -8.99x
Enterprise value
- Enterprise value
- HKD 3.6B
- EV / sales
- 331.98x
- EV / EBITDA
- -8.62x
- EV / EBIT
- -6.64x
- Market cap
- HKD 3.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026